Period Ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
Total Revenue | 4,896,320 | 5,351,672 | 6,436,803 | 6,040,619 |
Cost of Revenue | 4,111,536 | 4,469,395 | 5,315,016 | 4,997,746 |
Gross Profit | 784,784 | 882,277 | 1,121,787 | 1,042,873 |
Operating Expenses | ||||
Research Development | -- | -- | -- | -- |
Selling General and Administrative | -- | -- | 256,149 | -- |
Non Recurring | -- | -- | -- | -- |
Others | 657,632 | 727,462 | 650,774 | 814,286 |
Total Operating Expenses | 657,632 | 727,462 | 906,923 | 814,286 |
Operating Income or Loss | 127,152 | 154,815 | 214,864 | 228,587 |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (13,671) | (21,404) | (6,717) | 11,996 |
Earnings Before Interest And Taxes | 137,241 | 174,351 | 231,551 | 220,735 |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | 35,507 | 44,673 | 84,365 | 122,388 |
Income Tax Expense | 12,121 | 8,035 | 30,584 | 32,824 |
Minority Interest | 21,499 | 27,301 | 29,982 | 28,898 |
Net Income From Continuing Ops | 23,386 | 36,638 | 53,781 | 89,564 |
Non-recurring Events | ||||
Discontinued Operations | (5,447) | (103,386) | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | (1,905) | (1,485) | (3,291) | (5,624) |
Net Income | 16,034 | (68,233) | 50,490 | 83,940 |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | 16,034 | (68,233) | 50,490 | 83,940 |